The 5-HT1A receptor antagonist p-MPPI blocks responses mediated by postsynaptic and presynaptic 5-HT1A receptors. (Q48716431)

14 February 2018

title

The 5-HT1A receptor antagonist p-MPPI blocks responses mediated by postsynaptic and presynaptic 5-HT1A receptors. (English)

1 reference

14 February 2018

author name string

Allen AR

1

1 reference

14 February 2018

Singh A

2

1 reference

14 February 2018

Zhuang ZP

3

1 reference

14 February 2018

Kung MP

4

1 reference

14 February 2018

Kung HF

5

1 reference

14 February 2018

Lucki I

6

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 May 1997

1 reference

14 February 2018

Pharmacology, Biochemistry and Behavior

published in

1 reference

14 February 2018

volume

57

1 reference

14 February 2018

issue

1-2

1 reference

14 February 2018

page(s)

301-307

1 reference

14 February 2018

5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

Electrophysiological evidence for a large receptor reserve for inhibition of dorsal raphe neuronal firing by 5-HT1A agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

Subtypes of receptors for serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

The effects of a 5-HT1 receptor ligand isapirone (TVX Q 7821) on 5-HT synthesis and the behavioural effects of 5-HT agonists in mice and rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

Hypothermia in the rat induced by the potent serotoninergic agent 8-OH-DPAT

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

Buspirone: Effects on central monoaminergic transmission - possible relevance to animal experimental and clinical findings

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

Mixed agonist/antagonist properties of NAN-190 at 5-HT1A receptors: behavioural and in vivo brain microdialysis studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

An animal behavior model for studying central serotonergic synapses

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

A potential 5-HT1A receptor antagonist: p-MPPI.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

5-HT1 receptors and behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

Antidepressant-like behavioral effects of serotonin receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

Effect of the putative 5-HT1A antagonists WAY100135 and SDZ 216-525 on 5-HT neuronal firing in the guinea-pig dorsal raphe nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

Clinical Effects of the 5-HT1A Partial Agonists in Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

SDZ 216-525, a selective and potent 5-HT1A receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

The novel 5-HT1A receptor antagonist, SDZ 216-525, decreases 5-HT release in rat hippocampus in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

Effect of chronic treatments with tandospirone and imipramine on serotonin-mediated behavioral responses and monoamine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

Behavioral effects of 8-OH-DPAT: studies using the Microtaxic ventricular injector

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

BMY 7378, a buspirone analog with high affinity, selectivity and low intrinsic activity at the 5-HT1A receptor in rat and guinea pig hippocampal membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

Synthesis and evaluation of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p- iodobenzamido]ethyl]piperazine (p-MPPI): a new iodinated 5-HT1A ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900339-5

7 January 2021

10.1016/S0091-3057(96)00339-5

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018